CoChat

Increased central microglial activation associated with peripheral cytokine levels in premanifest Huntington's disease gene carriers

Open access
Politis, Marios, Lahiri, Nayana, Niccolini, Flavia, Su, Paul, Wu, Kit, Giannetti, Paolo, Scahill, Rachael I., Turkheimer, Federico E., Tabrizi, Sarah J., Piccini, Paola · 2015 · Neurobiology of Disease
Cited by 153

The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.

Abstract

Previous studies have shown activation of the immune system and altered immune response in Huntington's disease (HD) gene carriers. Here, we hypothesized that peripheral and central immune responses could be concurrent pathophysiological events and represent a global innate immune response to the toxic effects of mutant huntingtin in HD gene carriers. We sought to investigate our hypothesis using [(11)C]PK11195 PET as a translocator protein (TSPO) marker of central microglial activation, together with assessment of peripheral plasma cytokine levels in a cohort of premanifest HD gene carriers who were more than a decade from predicted symptomatic conversion. Data were also compared to those from a group of healthy controls matched for age and gender. We found significantly increased peripheral plasma IL-1β levels in premanifest HD gene carriers compared to the group of normal controls (P=0.018). Premanifest HD gene carriers had increased TSPO levels in cortical, basal ganglia and thalamic brain regions (P<0.001). Increased microglial activation in somatosensory cortex correlated with higher plasma levels of IL-1β (rs=0.87, P=0.013), IL-6 (rs=0.85, P=0.013), IL-8 (rs=0.68, P=0.045) and TNF-α (rs=0.79; P=0.013). Our findings provide first in vivo evidence for an association between peripheral and central immune responses in premanifest HD gene carriers, and provide further supporting evidence for the role of immune dysfunction in the pathogenesis of HD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.nbd.2015.08.011

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 14 references

Research works printed but not linked: 42

  1. Anderson, 2007, A systematic comparison of kinetic modelling methods generating parametric maps for [(11)C]-(R)-PK11195, NeuroImage, 36, 28, 10.1016/j.neuroimage.2007.02.017 · DOI
  2. Björkqvist, 2008, A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington's disease, J. Exp. Med., 205, 1869, 10.1084/jem.20080178 · DOI · Paper page
  3. Chang, 2015, Plasma inflammatory biomarkers for Huntington's disease patients and mouse model, Brain Behav. Immun., 44, 121, 10.1016/j.bbi.2014.09.011 · DOI
  4. Chen, 2000, Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease, Nat. Med., 6, 797, 10.1038/77528 · DOI · Paper page
  5. Craufurd, 2001, Behavioral changes in Huntington disease, Neuropsychiatry Neuropsychol. Behav. Neurol., 14, 219
  6. Crocker, 2006, DNA microarray analysis of striatal gene expression in symptomatic transgenic Huntington's mice (R6/2) reveals neuroinflammation and insulin associations, Brain Res., 1088, 176, 10.1016/j.brainres.2006.02.102 · DOI
  7. Ferrante, 1997, Heterogeneous topographic and cellular distribution of huntingtin expression in the normal human neostriatum, J. Neurosci., 17, 3052, 10.1523/JNEUROSCI.17-09-03052.1997 · DOI · Paper page
  8. Friedlander, 1996, Functional role of interleukin 1 beta (IL-1beta) in IL-1 beta-converting enzyme-mediated apoptosis, J. Exp. Med., 184, 717, 10.1084/jem.184.2.717 · DOI · Paper page
  9. Gousias, 2008, Automatic segmentation of brain MRIs of 2-year-olds into 83 regions of interest, NeuroImage, 40, 672, 10.1016/j.neuroimage.2007.11.034 · DOI · Paper page
  10. Gunn, 1997, Parametric imaging of ligand-receptor binding in PET using a simplified reference region model, NeuroImage, 6, 279, 10.1006/nimg.1997.0303 · DOI · Paper page
  11. Hammers, 2003, Three dimensional maximum probability atlas of the human brain, with particular reference to the temporal lobe, Hum. Brain Mapp., 19, 224, 10.1002/hbm.10123 · DOI · Paper page
  12. Hammers, 2007, Automatic detection and quantification of hippocampal atrophy on MRI in temporal lobe epilepsy: a proof-of-principle study, Neuroimage., 36, 38, 10.1016/j.neuroimage.2007.02.031 · DOI
  13. Heckemann, 2006, Automatic anatomical brain MRI segmentation combining label propagation and decision fusion, NeuroImage, 33, 115, 10.1016/j.neuroimage.2006.05.061 · DOI · Paper page
  14. Heckemann, 2010, Improving intersubject image registration using tissue-class information benefits robustness and accuracy of multi-atlas based anatomical segmentation, NeuroImage, 51, 221, 10.1016/j.neuroimage.2010.01.072 · DOI · Paper page
  15. Huntington Study Group, 1996, Unified Huntington's disease rating scale: reliability and consistency, Mov. Disord., 11, 136, 10.1002/mds.870110204 · DOI · Paper page
  16. Kemp, 2006, NEMA NU 2-2001 performance measurements of an LYSO-based PET/CT system in 2D and 3D acquisition modes, J. Nucl. Med., 47, 1960
  17. Khoshnan, 2004, Activation of the IkappaB kinase complex and nuclear factor-kappaB contributes to mutant huntingtin neurotoxicity, J. Neurosci., 24, 7999, 10.1523/JNEUROSCI.2675-04.2004 · DOI · Paper page
  18. Knudsen, 2008, Pre-analytical and biological variability in circulating interleukin 6 in healthy subjects and patients with rheumatoid arthritis, Biomarkers, 13, 59, 10.1080/13547500701615017 · DOI · Paper page
  19. Kwan, 2012, Mutant huntingtin impairs immune cell migration in Huntington disease, J. Clin. Invest., 122, 4737, 10.1172/JCI64484 · DOI · Paper page
  20. Langbehn, 2004, A new model for prediction of the age of onset and penetrance for Huntington's disease based on CAG length, Clin. Genet., 65, 267, 10.1111/j.1399-0004.2004.00241.x · DOI · Paper page
  21. McColl, 1994, Statistical methods in neuroimaging with particular application to emission tomography, Stat. Methods Med. Res., 3, 63, 10.1177/096228029400300105 · DOI
  22. Melton, 2003, Chronic glial activation, neurodegeneration, and APP immunoreactive deposits following acute administration of double-stranded RNA, Glia, 44, 1, 10.1002/glia.10276 · DOI · Paper page
  23. Montgomery, 2006, Correction of head movement on PET studies: comparison of methods, J. Nucl. Med., 47, 1936
  24. Nakanishi, 2003, Microglial functions and proteases, Mol. Neurobiol., 27, 163, 10.1385/MN:27:2:163 · DOI · Paper page
  25. Ona, 1999, Inhibition of caspase-1 slows disease progression in a mouse model of Huntington's disease, Nature, 399, 263, 10.1038/20446 · DOI · Paper page
  26. Penney, 1997, CAG repeat number governs the development rate of pathology in Huntington's disease, Ann. Neurol., 41, 689, 10.1002/ana.410410521 · DOI · Paper page
  27. Politis, 2008, Hypothalamic involvement in Huntington's disease: an in vivo PET study, Brain, 131, 2860, 10.1093/brain/awn244 · DOI · Paper page
  28. Quarantelli, 2004, Integrated software for the analysis of brain PET/SPECT studies with partial-volume-effect correction, J. Nucl. Med., 45, 192
  29. Reilmann, 2010, Tongue force analysis assesses motor phenotype in premanifest and symptomatic Huntington's disease, Mov. Disord., 25, 2195, 10.1002/mds.23243 · DOI
  30. Reilmann, 2011, Assessment of involuntary choreatic movements in Huntington's disease—toward objective and quantitative measures, Mov. Disord., 26, 2267, 10.1002/mds.23816 · DOI · Paper page
  31. Riess, 1993, Improved PCR conditions for the stretch of (CAG)n repeats causing Huntington's disease, Hum. Mol. Genet., 2, 637, 10.1093/hmg/2.6.637 · DOI · Paper page
  32. Silvestroni, 2009, Distinct neuroinflammatory profile in postmortem human Huntington's disease, Neuroreport, 20, 1098, 10.1097/WNR.0b013e32832e34ee · DOI · Paper page
  33. Stroop, 1935, Studies of interference in serial verbal reactions, J. Exp. Psychol., 18, 643, 10.1037/h0054651 · DOI · Paper page
  34. Studholme, 1997, Automated three-dimensional registration of magnetic resonance and positron emission tomography brain images by multiresolution optimization of voxel similarity measures, Med. Phys., 24, 25, 10.1118/1.598130 · DOI · Paper page
  35. Tabrizi, 2013, Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data, Lancet Neurol., 12, 637, 10.1016/S1474-4422(13)70088-7 · DOI · Paper page
  36. Träger, 2014, HTT-lowering reverses Huntington's disease immune dysfunction caused by NFκB pathway dysregulation, Brain, 137, 819, 10.1093/brain/awt355 · DOI · Paper page
  37. Trottier, 1995, Cellular localization of the Huntington's disease protein and discrimination of the normal and mutated form, Nat. Genet., 10, 104, 10.1038/ng0595-104 · DOI · Paper page
  38. Troy, 1996, The contrasting roles of ICE family proteases and interleukin-1beta in apoptosis induced by trophic factor withdrawal and by copper/zinc superoxide dismutase down-regulation, Proc. Natl. Acad. Sci. U. S. A., 93, 5635, 10.1073/pnas.93.11.5635 · DOI · Paper page
  39. Turkheimer, 1999, Multiresolution analysis of emission tomography images in the wavelet domain, J. Cereb. Blood Flow Metab., 19, 1189, 10.1097/00004647-199911000-00003 · DOI · Paper page
  40. Turkheimer, 2007, Reference and target region modeling of [11C]-(R)-PK11195 brain studies, J. Nucl. Med., 48, 158
  41. Warner, 1993, A new polymerase chain reaction (PCR) assay for the trinucleotide repeat that is unstable and expanded on Huntington's disease chromosomes, Mol. Cell. Probes, 7, 235, 10.1006/mcpr.1993.1034 · DOI · Paper page
  42. Yaqub, 2012, Optimization of supervised cluster analysis for extracting reference tissue input curves in (R)-[(11)C]PK11195 brain PET studies, J. Cereb. Blood Flow Metab., 32, 1600, 10.1038/jcbfm.2012.59 · DOI · Paper page

Cited by

See all 153

Metadata

Authors
Politis, M., Lahiri, N., Niccolini, F., Su, P., Wu, K., Giannetti, P., Scahill, R. I., Turkheimer, F. E., Tabrizi, S. J., & Piccini, P.
Venue
Neurobiology of Disease
Publisher
Elsevier BV
Published
2015-11
Volume
83
Pages
115-121
ISSN
0969-9961 (ISSN-L)
OpenAlex
W1149926701
Cited by
153
References
14
FWCI
5.50
Type
journal article
Language
en
Update notices
erratum (2017-02-01)
Open access
green
Licence
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
  • www.elsevier.com/legal/tdmrep-license (tdm)
Funders
  • Cure Huntington's Disease Initiative Foundation
  • Parkinson's UK
  • Edmond J. Safra Foundation
  • Michael J Fox Foundation
  • NIHR BRC

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Increased central microglial activation associated with peripheral cytokine levels in premanifest Huntington's disease gene carriers. https://app.cochat.ai/papers/10.1016/j.nbd.2015.08.011
The paper
Politis, M., Lahiri, N., Niccolini, F., Su, P., Wu, K., Giannetti, P., Scahill, R. I., Turkheimer, F. E., Tabrizi, S. J., & Piccini, P. (2015). Increased central microglial activation associated with peripheral cytokine levels in premanifest Huntington's disease gene carriers. Neurobiology of Disease. https://doi.org/10.1016/j.nbd.2015.08.011

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.